Keywords: Liver, Liver, function
Motivation: Interaction of drugs via inhibition of liver function affects their toxicity and efficacy, but this is currently difficult to assess clinically.
Goal(s): To determine if a DCE-MRI measurement of liver function is sufficiently sensitive to detect drug-induced inhibition of liver function in humans.
Approach: 10 healthy volunteers underwent a DCE-MRI measurement of their baseline liver function. The measurement was repeated on a second day after administration of rifampicin, a powerful inhibitor of liver function.
Results: Rifampicin reduced the hepatocellular uptake rate by 93%, and the effect was consistent between volunteers. The biliary excretion rate reduced by 48% and the effect was more variable.
Impact: Early clinical assessment of drug-drug interactions can significantly reduce the risk of expensive late-stage failures in drug development, potentially increasing the rate at which new drugs can enter the market, and reducing the risk to trial subjects and patients.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords